Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16061635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.

  2005cited by this paper
• Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• Minireview: Cyclin D1: normal and abnormal functions.

  2004cited by this paper
• Haplo-insufficiency of BRCA1 in sporadic breast cancer.

  2003cited by this paper
• Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor γ Expression and Transactivation

  2003cited by this paper
• p300 Modulates the BRCA1 inhibition of estrogen receptor activity.

  2002cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• BRCA1 transcriptionally regulates genes involved in breast tumorigenesis

  2002cited by this paper
• Specific protection against breast cancers by cyclin D1 ablation

  2001cited by this paper
• Gene-expression profiles in hereditary breast cancer.

  2001cited by this paper
• BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

  2001cited by this paper
• BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

  2001cited by this paper
• Hormonal Prevention of Hereditary Breast Cancer

  2001cited by this paper
• Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

  2001cited by this paper
• Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner.

  2001cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1.

  2000cited by this paper
• Estrogens, BRCA1, and breast cancer.

  2000cited by this paper
• BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.

  2000cited by this paper
• Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

  2000cited by this paper
• Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

  2000cited by this paper
• CBP/p300 interact with and function as transcriptional coactivators of BRCA1.

  2000cited by this paper
• Cyclin D1 Is Required for Transformation by Activated Neu and Is Induced through an E2F-Dependent Signaling Pathway

  2000cited by this paper
• hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

  2000cited by this paper
• Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1.

  1999cited by this paper
• Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

  1999cited by this paper
• The pathology of familial breast cancer: Immunohistochemistry and molecular analysis

  1999cited by this paper
• Brca1 controls homology-directed DNA repair.

  1999cited by this paper
• Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters

  1999cited by this paper
• Stat3 as an oncogene.

  1999cited by this paper
• The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation.

  1999cited by this paper
• The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

  1999cited by this paper
• BRCA1 inhibition of estrogen receptor signaling in transfected cells.

  1999cited by this paper
• Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.

  1999cited by this paper
• Binding of CtIP to the BRCT Repeats of BRCA1 Involved in the Transcription Regulation of p21 Is Disrupted Upon DNA Damage*

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• BRCA1 interacts with components of the histone deacetylase complex.

  1999cited by this paper
• Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers.

  1998cited by this paper
• An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non‐familial breast cancers

  1998cited by this paper
• BRCA1 regulates p53-dependent gene expression.

  1998cited by this paper
• Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1.

  1998cited by this paper
• Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.

  1997cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• CDK-independent activation of estrogen receptor by cyclin D1.

  1997cited by this paper
• Cancer-susceptibility genes. Gatekeepers and caretakers.

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

  1994cited by this paper
• Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.

  1987cited by this paper

• A New Class of BRCA1 Mimetics for ERα-Positive Breast Cancer Therapy: Design, Synthesis, In Silico Screening, In Vitro Assay, and Gene Expression Analysis

  2025cites this paper
• TRIM21-mediated ubiquitination of SIX2 attenuates breast cancer stemness via LGSN suppression

  2025cites this paper
• Targeting the DNA damage response through TBL1X in mantle cell lymphoma

  2025cites this paper
• Human Cancers Derived from Either Genetic or Lifestyle Factors Are Initiated by Impaired Estrogen Signaling

  2025cites this paper
• DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care

  2024cites this paper
• Genome-wide expression profiling reveals novel biomarkers in epithelial ovarian cancer.

  2023cites this paper
• Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?

  2023cites this paper
• Piper chaba, an Indian spice plant extract, inhibits cell cycle G1/S phase transition and induces intrinsic apoptotic pathway in luminal breast cancer cells

  2023cites this paper
• The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen

  2022cites this paper
• Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis

  2021cites this paper
• The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression

  2021cites this paper
• Multifunctionality of Prostatic Acid Phosphatase in Prostate  Cancer Pathogenesis.

  2021cites this paper
• Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype

  2020cites this paper
• Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma

  2020cites this paper
• Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis.

  2020cites this paper
• Compensatory Estrogen Signal Is Capable of DNA Repair in Antiestrogen-Responsive Cancer Cells via Activating Mutations

  2020cites this paper
• The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer

  2020cites this paper
• Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER Positive Breast Cancer Therapy.

  2020cites this paper
• Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

  2019cites this paper
• The double dealing of cyclin D1

  2019cites this paper
• Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology

  2019cites this paper
• A novel function for cyclin D1 as a transcriptional role in oncogenesis and tumor development by ChIP-Seq and RNA-Seq

  2019cites this paper
• Cyclin D 1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB 1 Signaling Axis

  2018cites this paper
• D-type Cyclins and Cancer

  2018cites this paper
• Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB1 Signaling Axis.

  2017cites this paper
• NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of BRCA1-Mutated Breast Cancer

  2017cites this paper
• Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer

  2017cites this paper
• Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer.

  2017cites this paper
• Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells.

  2016cites this paper
• Sexual dimorphism in gene expression and regulatory networks across human tissues

  2016cites this paper
• Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations

  2016cites this paper
• Paradoxical roles of cyclin D1 in DNA stability.

  2016cites this paper
• Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage

  2015cites this paper
• Exploring the epigenetic link in circadian disruption induced breast cancer

  2015influential citation
• Circadian disruption and breast cancer: An epigenetic link?

  2015cites this paper
• Involvement of cyclin D1 and E2f1 in zearalenone-induced DNA damage in testis of rats.

  2015cites this paper
• DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers

  2015influential citation
• BRCA1 and Oxidative Stress

  2014cites this paper
• Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers

  2014cites this paper
• Cyclin D1 integrates estrogen-mediated DNA damage repair signaling.

  2014cites this paper
• BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?

  2014cites this paper
• Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development

  2014cites this paper
• Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.

  2014cites this paper
• A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancers

  2014cites this paper
• LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer

  2014cites this paper
• Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation.

  2013cites this paper
• New roles of cyclin D1.

  2013cites this paper
• Epigenetic regulation of estrogen signaling in breast cancer

  2013cites this paper
• Cyclin D1 determines estrogen signaling in the mammary gland in vivo.

  2013cites this paper
• Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer

  2012cites this paper
• Proteomic identification of a direct role for cyclin d1 in DNA damage repair.

  2012cites this paper
• Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer

  2012cites this paper
• Prognosis of Treatment Response (Pathological Complete Response) in Breast Cancer

  2012cites this paper
• BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site

  2012cites this paper
• ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.

  2012cites this paper
• Proteomic Identi fi cation of a Direct Role for Cyclin D 1 in DNA Damage Repair

  2012cites this paper
• Cyclins and cell cycle control in cancer and disease.

  2012cites this paper
• Down-regulation of estrogen receptor α (ERα) transcriptional activity by p27 is mediated by inhibition of ERα nuclear localization and modulation of the ERα transcriptional complex.

  2012cites this paper
• The circadian clock and the cell cycle

  2012cites this paper
• Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models

  2011cites this paper
• PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b

  2011cites this paper
• Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1

  2011cites this paper
• Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature

  2011cites this paper
• Shift work and cancer - considerations on rationale, mechanisms, and epidemiology.

  2010cites this paper
• Attenuation of Forkhead signaling by the retinal determination factor DACH1

  2010cites this paper
• BP1, an Isoform of DLX4 Homeoprotein, Negatively Regulates BRCA1 in Sporadic Breast Cancer

  2010cites this paper
• OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-kappaB pathway and stress response signaling.

  2009cites this paper
• BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells

  2009cites this paper
• Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.

  2009cites this paper
• BRCA1 Cross-Talk with Hormone Receptors.

  2009cites this paper
• Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue‐specific intervention possible?

  2009influential citation
• Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1.

  2009cites this paper
• Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription.

  2009cites this paper
• High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics

  2008cites this paper
• Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration*

  2008cites this paper
• Iodine Alters Gene Expression in the MCF7 Breast Cancer Cell Line: Evidence for an Anti-Estrogen Effect of Iodine

  2008influential citation
• Acetylation in nuclear receptor signaling and the role of sirtuins.

  2008cites this paper
• BRCA1, Hormone, and Tissue-Specific Tumor Suppression

  2008cites this paper
• Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity.

  2007cites this paper
• The functional significance of nuclear receptor acetylation.

  2007cites this paper
• Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.

  2007cites this paper
• Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells

  2007cites this paper
• Mechanisms of growth arrest by zinc ribbon domain-containing 1 in gastric cancer cells.

  2007cites this paper
• Circadian Clock and Breast Cancer: A Molecular Link

  2007cites this paper
• Epigenetic regulation of nuclear steroid receptors.

  2006cites this paper
• The role of BRCA1 in transcriptional regulation and cell cycle control

  2006cites this paper
• BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions

  2006cites this paper
• The cyclin D1b splice variant: an old oncogene learns new tricks

  2006cites this paper
• Epigenetics and the Estrogen Receptor

  2006cites this paper
• Basic science (August 2005)

  2006cites this paper
• 4. Mechanistic and Other Relevant Data 4.1 the Pineal Gland and Melatonin

  year unknowncites this paper